Genomic instability drives tumorigenesis and metastasis and its implications for cancer therapy - 08/12/22


Abstract |
Genetic instability can be caused by external factors and may also be associated with intracellular damage. At the same time, there is a large body of research investigating the mechanisms by which genetic instability occurs and demonstrating the relationship between genomic stability and tumors. Nowadays, tumorigenesis development is one of the hottest research areas. It is a vital factor affecting tumor treatment. Mechanisms of genomic stability and tumorigenesis development are relatively complex. Researchers have been working on these aspects of research. To explore the research progress of genomic stability and tumorigenesis, development, and treatment, the authors searched PubMed with the keywords "genome instability" "chromosome instability" "DNA damage" "tumor spread" and "cancer treatment". This extracts the information relevant to this study. Results: This review introduces genomic stability, drivers of tumor development, tumor cell characteristics, tumor metastasis, and tumor treatment. Among them, immunotherapy is more important in tumor treatment, which can effectively inhibit tumor metastasis and kill tumor cells. Breakthroughs in tumorigenesis development studies and discoveries in tumor metastasis will provide new therapeutic techniques. New tumor treatment methods can effectively prevent tumor metastasis and improve the cure rate of tumors.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | The organism regulates the stability of the genome through the conversion of certain pathways and specific structures. |
• | Most tumor metastases occur when tumors escape from the body's immune system. |
• | Targeted therapies can efficiently inhibit tumor metastasis. |
• | Chromosomal instability could predict outcomes after tumor treatment. |
Abbreviations : ATR, BRCA2, cGAS, CIN, Cas9, CNVs, CDC20-M, CAR-T, CTLA-4, DSB, ecDNA, DDX41, DCs, HI-SC2, HRD, lncRNA, KDM5B, LncRNA, MCM10, mTOR-S6K, MR1, MYO10, NSPCs, NORAD, NSCLC, SIRT6, STING, SOG1, scRNA-seq, SCNAs, TOP2A, PHB3, PUM, Pds5B, PD-1, Rtt107, RNASEH1
Keywords : Chromosome instability, DNA damage, Genome stability, Tumor metastasis, Tumor therapy
Plan
Vol 157
Article 114036- janvier 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?